51 related articles for article (PubMed ID: 28843636)
1. Management of Sickle Cell Pain Using Pregabalin: A Pilot Study.
Schlaeger JM; Molokie RE; Yao Y; Suarez ML; Golembiewski J; Wilkie DJ; Votta-Velis G
Pain Manag Nurs; 2017 Dec; 18(6):391-400. PubMed ID: 28843636
[TBL] [Abstract][Full Text] [Related]
2. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.
Toth C
Ther Adv Drug Saf; 2014 Feb; 5(1):38-56. PubMed ID: 25083261
[TBL] [Abstract][Full Text] [Related]
3. Promise of Composite Pain Index as a single pain outcome for sickle cell disease across the lifespan.
Kashif R; Wallace-Farquharson T; Adams-Mitchell C; Yao Y; Molokie RE; Wilkie DJ; Mack AK
Pediatr Blood Cancer; 2024 Jun; 71(6):e30958. PubMed ID: 38572597
[TBL] [Abstract][Full Text] [Related]
4. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
Puri L; Nottage KA; Hankins JS; Anghelescu DL
Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin reduces opioid consumption and hyperalgesia but not pain intensity after laparoscopic donor nephrectomy.
Myhre M; Romundstad L; Stubhaug A
Acta Anaesthesiol Scand; 2017 Nov; 61(10):1314-1324. PubMed ID: 28849588
[TBL] [Abstract][Full Text] [Related]
6. Anti‑inflammatory actions of gabapentin and pregabalin on the substance P‑induced mitogen‑activated protein kinase activation in U373 MG human glioblastoma astrocytoma cells.
Yamaguchi K; Kumakura S; Someya A; Iseki M; Inada E; Nagaoka I
Mol Med Rep; 2017 Nov; 16(5):6109-6115. PubMed ID: 28849160
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell disease: Classification of clinical complications and approaches to preventive and therapeutic management.
Ballas SK
Clin Hemorheol Microcirc; 2018; 68(2-3):105-128. PubMed ID: 29614627
[TBL] [Abstract][Full Text] [Related]
8. Inducing indel mutation in the SOX6 gene by zinc finger nuclease for gamma reactivation: An approach towards gene therapy of beta thalassemia.
Modares Sadeghi M; Shariati L; Hejazi Z; Shahbazi M; Tabatabaiefar MA; Khanahmad H
J Cell Biochem; 2018 Mar; 119(3):2512-2519. PubMed ID: 28941328
[TBL] [Abstract][Full Text] [Related]
9. Sickle cell disease and the unmet challenges of neurologic complications.
Birbeck GL; Green R
Neurology; 2017 Oct; 89(14):1439-1440. PubMed ID: 28864677
[No Abstract] [Full Text] [Related]
10. Associations between endothelial dysfunction and clinical and laboratory parameters in children and adolescents with sickle cell anemia.
Teixeira RS; Terse-Ramos R; Ferreira TA; Machado VR; Perdiz MI; Lyra IM; Nascimento VL; Boa-Sorte N; Andrade BB; Ladeia AM
PLoS One; 2017; 12(9):e0184076. PubMed ID: 28863145
[TBL] [Abstract][Full Text] [Related]
11. Pregbalin induced recurrent syncopal attacks with prolong QT interval.
Adar A; Cakan F; Önalan O
Ann Noninvasive Electrocardiol; 2018 Jul; 23(4):e12489. PubMed ID: 28856762
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy.
Audard V; Bartolucci P; Stehlé T
Clin Kidney J; 2017 Aug; 10(4):475-478. PubMed ID: 28852484
[TBL] [Abstract][Full Text] [Related]
13. A Single Preoperative Administration of Dexamethasone, Low-dose Pregabalin, or a Combination of the 2, in Spinal Surgery, Does Not Provide a Better Analgesia Than a Multimodal Analgesic Protocol Alone.
Momon A; Verdier B; Dolomie JO; Gardette M; Pereira B; Curt I; Dualé C
Clin J Pain; 2019 Jul; 35(7):594-601. PubMed ID: 31021886
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P
Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
16. Neuropathic pain in individuals with sickle cell disease.
Sharma D; Brandow AM
Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
[TBL] [Abstract][Full Text] [Related]
17. Key Components of Pain Management for Children and Adults with Sickle Cell Disease.
Brandow AM; DeBaun MR
Hematol Oncol Clin North Am; 2018 Jun; 32(3):535-550. PubMed ID: 29729787
[TBL] [Abstract][Full Text] [Related]
18. Patient and clinician beliefs about potential barriers to treatment of neuropathic pain for adolescents with sickle cell disease.
Rees M; Spraker-Perlman H; Moore R; Lavoie P; Schiff L; Allen JM; Rai P; Anghelescu DL
EJHaem; 2024 Feb; 5(1):11-20. PubMed ID: 38406507
[TBL] [Abstract][Full Text] [Related]
19. Emerging Therapies for the Management of Pain and Vaso-Occlusive Crises in Patients With Sickle Cell Disease: A Systematic Review of Randomized Controlled Trials.
Lowe M; Bambhroliya Z; Patel H; Patel VJ; Vudugula SA; Cheruvu NP; Raza S; Okunlola OI
Cureus; 2023 Apr; 15(4):e38014. PubMed ID: 37223201
[TBL] [Abstract][Full Text] [Related]
20. Validation of the tablet-based Turkish-PAINReportIt® for lung cancer patients after thoracotomy in Turkey.
Erden S; Yikar SK; Doğan SD; Lucero RJ; Yıldız KS; Gezer S; Nazik E; Arslan S; Yao Y; Wilkie DJ
Appl Nurs Res; 2023 Apr; 70():151673. PubMed ID: 36933901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
